Castle Biosciences – IDENTITY Study (CBI_2021_ISD_DevVal_001)
Do you have Psoriasis or Atopic Dermatitis (Eczema) and want to participate in a clinical research study with the goal of developing a new test that can predict treatment response?
If so, the IDENTITY Study may be for you!
We are looking for patients with clinically diagnosed moderate to severe Atopic Dermatitis (Eczema) or Psoriasis who:
Are being considered for a systemic treatment.
OR
Are planning to switch from current systemic treatment to a new one.
Other study eligibility criteria apply and will be determined at the screening or initial study visit. Qualified participants may receive compensation for their time and travel.
Contact us to see if you are a candidate for this study.
Castle Biosciences - Squamous Cell Carcinoma Study (CBl_2019_cSCC_PVS_001)
Castle Biosciences is conducting an observational study for squamous cell carcinoma. The study is a 3-year study that follows your health progression in 6-month increments, and no changes to your standard care will occur during your participation in the study. Initial enrollment will be determined by your health care provider, and it is based on a squamous cell carcinoma diagnosis meeting specific criteria.
DermTech is researching whether the use of their investigational adhesive patch biopsy kit can help in the detection of melanoma. Enrollment in the study is based on your care provider finding a pigmented lesion(s) that is (are) suspected to be melanoma. Stickers are applied to the lesion(s) and the results are compared to the standard shave biopsy that will be collected during the visit. The study is a one-day study with no follow-up visits.
Browse Our Website
Contact Information
Phone: 858-292-5101
Fax: 858-292-1915
Address:
5222 Balboa Ave, Floors 5 & 6, San Diego, CA 92117
Business Hours
- Mon - Thu
- -
- Fri - Sun
- Closed
